Home/Filings/4/0001140361-16-066307
4//SEC Filing

Aeglea BioTherapeutics, Inc. 4

Accession 0001140361-16-066307

$SYRECIK 0001636282operating

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:39 PM ET

Size

5.4 KB

Accession

0001140361-16-066307

Insider Transaction Report

Form 4
Period: 2016-05-17
TYLER JOSEPH E
VP, Manufacturing
Transactions
  • Award

    Employee Stock Option (right to buy)

    2016-05-17+33,00033,000 total
    Exercise: $7.28Exp: 2026-05-16Common Stock (33,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on June 17, 2016, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Documents

1 file

Issuer

Aeglea BioTherapeutics, Inc.

CIK 0001636282

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001636282

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:39 PM ET
Size
5.4 KB